Pharming Group NV(PHARM) News

Date	Title
Oct 10	Pharming Group to report third quarter 2024 financial results on October 24
Aug 9	Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan